ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lafuma, C
Right arrow Articles by Hornebeck, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lafuma, C
Right arrow Articles by Hornebeck, W
Eur Respir J 1991; 4: 1004-1009
Copyright © ERS Journals Ltd 1991


Original Articles

Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments

C Lafuma, E Frisdal, A Harf, L Robert, and W Hornebeck

Heparin and its derivatives inhibit human leucocyte proteinases i.e. elastase and cathepsin G, but do not inhibit porcine pancreatic elastase and Pseudomonas aeruginosa elastase. In vitro experiments, reported here, also indicate that elastin, one of the physiological substrates of human leucocyte elastase (HLE), could decrease by 30-fold the inhibitory potential of an hexadecasaccharide heparin fragment (dp 16) isolated from CY 222. Nevertheless, the inhibitory capacity of the heparin fragment still remains elevated with IC50 = 2.7 x 10(-7) M and still inhibits HLE in its free and adsorbed state to elastin. These overall data prompted us to evaluate the influence of CY 222 in HLE-induced emphysema. Emphysema was induced in mice eight weeks old, following a single instillation of 200 micrograms of HLE. CY 222 treated animals received 2.5 mg.kg-1 subcutaneously once daily, 6 days per week during 4 weeks prior to HLE instillation, and for eight weeks following HLE instillation. The heparin fragment treatment of the mice halved the mortality rate observed early following HLE instillation. After 8 weeks, surviving animals were examined for lung histological and morphometrical changes: mean linear intercept (MLI) and internal alveolar area (ISA). The CY 222 heparin fragments exerted a protective effect against HLE-induced emphysema by decreasing by 70% the MLI; these heparin fragments exerted no effect on emphysema induced by pancreatic elastase in hamsters or mice. Heparin derivatives represent a new class of physiological HLE low molecular weight inhibitors capable of preventing HLE-induced emphysema.


This article has been cited by other articles:


Home page
ThoraxHome page
R Mahadeva and S D Shapiro
Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema
Thorax, October 1, 2002; 57(10): 908 - 914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Negrini, A. Passi, G. De Luca, and G. Miserocchi
Proteoglycan involvement during development of lesional pulmonary edema
Am J Physiol Lung Cell Mol Physiol, February 1, 1998; 274(2): L203 - L211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Cadene, J. Duranton, A. North, M. Si-Tahar, M. Chignard, and J. G. Bieth
Inhibition of Neutrophil Serine Proteinases by Suramin
J. Biol. Chem., April 11, 1997; 272(15): 9950 - 9955.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the European Respiratory Society.